Page 63 - 81_02

Reactive oxygen species and vascular remodeling in cardiovascular diseases
NOX4 in the pulmonary vasculature. Circ Res 2007;
101: 258-67.
79. Diebold I, Petry A, Hess J, Görlach A. The NADPH
oxidase subunit NOX4 is a new target gene of the
hypoxia-inducible factor-1. Mol Biol Cell 2010; 21:
2087-96.
80. Cucoranu I, Clempus R, Dikalova A, Phelan PJ,
Ariyan S, Dikalov S, Sorescu D. NAD(P)H oxidase 4
mediates transforming growth factor-beta1-induced
differentiation of cardiac fibroblasts into
myofibroblasts. Circ Res 2005; 97: 900-7.
81. Sturrock A, Cahill B, Norman K, Huecksteadt TP,
Hill K, Sanders K, Karwande SV, Stringham JC, Bull
DA, Gleich M, Kennedy TP, Hoidal JR. Transforming
growth factor-beta1 induces Nox4 NAD(P)H oxidase
and reactive oxygen species-dependent proliferation in
human pulmonary artery smooth muscle cells. Am J
Physiol Lung Cell Mol Physiol 2006; 290: L661-73.
82. Sturrock A, Huecksteadt TP, Norman K, Sanders K,
Murphy TM, Chitano P, Wilson K, Hoidal JR,
Kennedy TP. Nox4 mediates TGF-beta1-induced
retinoblastoma protein phosphorylation, proliferation,
and hypertrophy in human airway smooth muscle
cells. Am J Physiol Lung Cell Mol Physiol 2007; 292:
L1543-55.
83. Ellmark SHM, Dusting GJ, Tang Fui MN, Guzzo-
Pernell N, Drummond GR The contribution of Nox4
to NADPH oxidase activity in mouse vascular smooth
muscle. Cardiovasc Res 2005; 65: 495-504.
84. Hwang J, Kleinhenz DJ, Lassègue B, Griendling KK,
Dikalov S, Hart CM. Peroxisome proliferator-
activated receptor-gamma ligands regulate endothelial
membrane superoxide production. Am J Physiol Cell
Physiol 2005; 288: C899-905.
85. Richard D, Wolf C, Barbe U, Kefi K, Bausero P,
Visioli F. Docosahexaenoic acid down-regulates
endothelial Nox 4 through a sPLA2 signalling
pathway. Biochem Biophys Res Commun 2009; 389:
516-22.
86. Wind S, Beuerlein K, Armitage ME, Taye A, Kumar
AH, Janowitz D Neff C, Shah AM, Wingler K,
Schmidt HH. Oxidative stress and endothelial
dysfunction in aortas of aged spontaneously
hypertensive rats by NOX1/2 is reversed by NADPH
oxidase inhibition. Hypertension 2010; 56: 490-7.
87. Paravicini TM, Chrissobolis S, Drummond GR Sobey
CG. Increased NADPH oxidase activity and Nox4
expression during chronic hypertension is associated
with enhanced cerebral vasodilatation to NADPH in
vivo. Stroke 2004; 35: 584-9.
88. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz
E, Oelze M, Li H, Bodenschatz M, August M,
Kleschyov AL, Tsilimingas N, Walter U, Förstermann
U, Meinertz T, Griendling K, Münzel T. Effects of
angiotensin II infusion on the expression and function factor is crucial for transcriptional activation of the
of NAD(P)H oxidase and components of nitric
oxide/cGMP signaling. Circ Res 2002; 90: E58-65.
89. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi
M, Kagami S, Kondo S, Kiyomoto H, Shokoji T,
@Real Academia Nacional de Farmacia. Spain
Kimura S, Kohno M, Abe Y. Possible contributions of
reactive oxygen species and mitogen-activated protein
kinase to renal injury in aldosterone/salt-induced
hypertensive rats. Hypertension 2004; 43: 841-8.
90. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker
EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG,
Drummond GR. Direct evidence of a role for Nox2 in
superoxide production, reduced nitric oxide
bioavailability, and early atherosclerotic plaque
formation in ApoE-/-mice. Am J Physiol Heart Circ
Physiol 2010; 298: H24-32.
91. Stanic B, Pandey D, Fulton DJ, Miller FJ Jr. Increased
epidermal growth factor-like ligands are associated
with elevated vascular nicotinamide adenine
dinucleotide phosphate oxidase in a primate model of
atherosclerosis. ArteriosclerThromb Vasc Biol 2012;
32: 2452-60.
92. Katsuyama M, Matsuno K, Yabe-Nishimura C.
Physiological roles of NOX/NADPH oxidase, the
superoxide-generating enzyme. J Clin Biochem Nutr
2012; 50: 9-22.
93. Zhang L, Sheppard OR, Shah AM, Brewer AC.
Positive regulation of the NADPH oxidase NOX4
promoter in vascular smooth muscle cells by E2F.
Free Radic Biol Med 2008; 45: 679-85.
94. Katsuyama M, Hirai H, Iwata K, Ibi M, Matsuno K,
Matsumoto M, Yabe-Nishimura C. Sp3 transcription
human NOX4 gene. FEBS J 2011; 278: 964-72.
95. Siuda D, Zechner U, El Hajj N, Prawitt D, Langer D,
Xia N, Horke S, Pautz A, Kleinert H, Förstermann U,
Li H. Transcriptional regulation of Nox4 by histone
deacetylases in human endothelial cells. Basic Res
Cardiol 2012; 107: 283.
96. Paneni F, Osto E, Costantino S, Mateescu B, Briand
S, Coppolino G, Perna E, Mocharla P, Akhmedov A,
Kubant R, Rohrer L, Malinski T, Camici GG, Matter
CM, Mechta-Grigoriou F, Volpe M, Lüscher TF,
Cosentino F. Deletion of the activated protein-1
transcription factor JunD induces oxidative stress and
accelerates age-related endothelial dysfunction.
Circulation 2013; 127: 1229-40, e1-21.
97. Varga ZV, Kupai K, Szucs G, Gáspár R, Pálóczi J,
Faragó N, Zvara A, Puskás LG, Rázga Z, Tiszlavicz
L, Bencsik P, Görbe A, Csonka C, Ferdinandy P,
Csont T. MicroRNA-25-dependent up-regulation of
NADPH oxidase 4 (NOX4) mediat es
hypercholesterolemia-induced oxidative/nitrative
stress and subsequent dysfunction in the heart. J Mol
Cell Cardiol 2013; 62: 111-21.
98. Peshavariya H, Jiang F, Taylor CJ, Selemidis S,
Chang CW, Dusting GJ. Translation-linked mRNA
destabilization accompanying serum-induced Nox4
expression in human endothelial cells. Antioxid
Redox Signal 2009; 11: 2399-408.
99. Raaz U, Toh R, Maegdefessel L, Adam M, Nakagami
F, Emrich FC, Spin JM, Tsao PS. Hemodynamic
regulation of reactive oxygen species: implications for
143